小剂量甲氨蝶呤治疗异位妊娠的药动学研究

梁健健;王娟;吕军;俞丽萍

中国药学杂志 ›› 2005, Vol. 39 ›› Issue (13) : 1034-1035.

中国药学杂志 ›› 2005, Vol. 39 ›› Issue (13) : 1034-1035.
药物与临床

小剂量甲氨蝶呤治疗异位妊娠的药动学研究

  • 梁健健;王娟;吕军;俞丽萍
作者信息 +

Pharmacokinetics of low-dose methotrexate in treatment of ectopic pregnancy

  • LIANG Jian-jian1,WANG Juan1,L Jun2,YU Li-ping2
Author information +
文章历史 +

摘要

目的研究小剂量甲氨蝶呤(MTX)治疗异位妊娠的药动学。方法12例异位妊娠患者肌注MTX20mg。于给药前和给药后0.17,0.5,1,2,3,4,6,8,12和24h抽取静脉血,采用荧光偏振免疫分析法(FPIA)测定MTX血药浓度。用3P97软件计算其药动学参数。结果小剂量肌注MTX符合开放二室动力学模型。结论此研究结果有助于甲氨蝶呤合理应用,为临床用药提供理论依据。

Abstract

OBJECTIVE To investigate the pharmacokinetic parameters of low-dose methotrexate in the treatment of ectopic pregnancy. METHODS After a single intramuscular admintration of methotrexate 20 mg was given to 12 patients with ectopic pregnancy, the serum samples were collected from 0 to 24 h. MTX concentration in serum was measured by fluorescence polarization immunoassay(FPIA) .The pharmacokinetic parameter were calculated with 3P97 program software. RESULTS The pharmacokinetic profile of low-dose metholrexate in patients with ectopic pregnancy was described by a two-compartment open model. CONCLUSION These results may be helpful to a rational individualized methodtrexate dosage regimen.

关键词

甲氨蝶呤 / 药动学 / 异位妊娠

Key words

methotrexate / pharmacokinetics / ectopic pregnancy

引用本文

导出引用
梁健健;王娟;吕军;俞丽萍. 小剂量甲氨蝶呤治疗异位妊娠的药动学研究[J]. 中国药学杂志, 2005, 39(13): 1034-1035
LING Jin-jin;WNG Jun;L Jun;YU Li-ping. Pharmacokinetics of low-dose methotrexate in treatment of ectopic pregnancy [J]. Chinese Pharmaceutical Journal, 2005, 39(13): 1034-1035

参考文献

[1]陈新谦,金有豫,汤光. 新编药物学[M]. 第15版. 北京:人民卫生出版社,2002:672~708. [2]Tanaka T,Hayashi H,Kutsuzawa T, et al.Treatment of interstital ectopic pregnancy with methotrexate:report of a successful case[J].Fertil Steril,1982,37(6):851. [3]Erdem M,Erdem A,Arslan M,et al.Single-dose methotrexate for the treatment of unruptured ectopic pregnancy[J].Arch Gynecol Obstet,2004,270(4):235. [4]el-Lamie IK,Shehata NA,Kamel HA.Intramuscular methotrexate for tubal pregnancy[J].J Reprod,2002,47(2):144. [5]Aquerreta I,Aldaz A,Giraldez J,et al. Methotrexate pharmacokinetics and survival in osteosarcma[J].Pediatr Blood Cancer,2004,42(1):52. [6]Hoekstra M,Haagsma C,Neef C. et al. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis[J].J Rheumatol,2004,31(4):645. [7]彭健,姚敏元.大剂量甲氨喋呤治疗儿童急性淋巴细胞白血病的药代动力学.中国药房,1996,7(2):77.

基金

广东省医学科学技术研究基金课题(2001)

Accesses

Citation

Detail

段落导航
相关文章

/